APA (7th ed.) Citation

Ott, C., Kopp, N., Bird, L., Paranal, R., Qi, J., Bowman, T., . . . Bradner, J. (2012). 539 BET Bromodomain Inhibition Targets Both c-Myc and IL7R in Acute Lymphoblastic Leukemia. European Journal of Cancer, 48, 166. https://doi.org/10.1016/S0959-8049(12)72336-5

Chicago Style (17th ed.) Citation

Ott, C., et al. "539 BET Bromodomain Inhibition Targets Both C-Myc and IL7R in Acute Lymphoblastic Leukemia." European Journal of Cancer 48 (2012): 166. https://doi.org/10.1016/S0959-8049(12)72336-5.

MLA (9th ed.) Citation

Ott, C., et al. "539 BET Bromodomain Inhibition Targets Both C-Myc and IL7R in Acute Lymphoblastic Leukemia." European Journal of Cancer, vol. 48, 2012, p. 166, https://doi.org/10.1016/S0959-8049(12)72336-5.